CUSIP: 43358V109
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,531,774
-
Share change
-
+5,393,924
-
Total reported value
-
$60,850,000
-
Price per share
-
$11.00
-
Number of holders
-
13
-
Value change
-
+$59,333,000
-
Number of buys
-
11
Quarterly Holders Quick Answers
What is CUSIP 43358V109?
CUSIP 43358V109 identifies HSGX - HISTOGENICS CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 43358V109:
Institutional Holders of HISTOGENICS CORP - COM (HSGX) as of Q4 2014
As of 31 Dec 2014,
HISTOGENICS CORP - COM (HSGX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,531,774 shares.
The largest 10 holders included
Third Security, LLC, FMR LLC, Palo Alto Investors, LLC, TURNER INVESTMENTS, L.P., Longwood Capital Partners LLC, SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, UBS OCONNOR LLC, and MORGAN STANLEY.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.